Blog: Our Insights
Your resource for industry news and updates from Broughton.

Reflections on the 75th Tobacco Science Research ...

September 20, 2022

Broughton Senior Consultant for Chemistry, Malcolm Saxton reflects on the 75th Tobacco Science Research Conference (TSRC) and the progress ...

Broughton gains new regulatory insight while ...

May 18, 2022

Broughton celebrates Premarket Tobacco Product Application (PMTA) success for clients.   

Designing an NGP and Making it Market-Ready

April 11, 2022

Broughton's Chief Scientific and Regulatory Officer Dr. Nveed Chaudhary talks to leading sector publication Tobacco Asia about ...

Broughton explains how the FDA’s new powers to ...

March 29, 2022

Broughton's Chief Scientific and Regulatory Officer, Dr Nveed Chaudhary has published an article on the recent FDA announcement on ...

2022 will define the future of ENDS

February 24, 2022

Broughton's Chief Scientific and Regulatory Officer, Dr Nveed Chaudhary discusses what developments are expected over the next 12 months ...

FDA final rule for PMTA applications

October 28, 2021

Broughton's Head of Regulatory Affairs, Lloyd Smart discusses Food and Drug Administration (FDA) final ruling for Premarket Tobacco Product ...

GTNF 2021 - Industry reflections

October 8, 2021

Broughton's Chief Regulatory Officer, Dr Nveed Chaudhary shares his post-event reflections on Global Tobacco Nicotine Forum (GTNF) 2021.

Broughton join world-leading experts at GTNF 2021

September 17, 2021

Broughton Chief Scientific Officer, Chris Allen shares his thoughts ahead of this year's Global Tobacco & Nicotine Forum (GTNF) taking ...

FDA update - disappointing news or an opportunity?

September 10, 2021

Broughton Chief Regulatory Officer, Dr. Nveed Chaudhary shares his thoughts on yesterday's announcement from the Food and Drug ...

What the latest FDA updates mean for ENDS ...

September 7, 2021

Broughton Chief Regulatory Officer, Dr. Nveed Chaudhary shares his thoughts on the latest Food and Drug Administration (FDA) updates ...

Clinical trials, timescales, and supplementing ...

August 9, 2021

Broughton asked industry expert, Dr Ian Fearon, to explain the process followed when running clinical trials.

Deficiency letters - common causes and how to ...

August 5, 2021

Broughton Head of Scientific Affairs, Paul Hardman has today published an article with leading sector publication Tobacco Reporter that ...

Achieving a sustainable smoke-free future is the ...

July 27, 2021

Broughton Chief Regulatory Officer, Dr. Nveed Chaudhary, discusses the global challenges the ENDS industry faces to achieve a smoke-free ...

US Food and Drug Administration (FDA) Centre for ...

June 16, 2021

Broughton Chief Regulatory Officer, Dr. Nveed Chaudhary, summarises the latest US Food and Drug Administration (FDA) Centre for Tobacco ...

FDA PMTA 90-day deficiency letters – what next?

June 1, 2021

Broughton Head of Scientific Affairs, Paul Hardman outlines factors that can lead to data gaps in Premarket Tobacco Product  Applications ...

Broughton welcomes Paul Hardman as our new Head ...

May 6, 2021

Broughton is delighted to announce that Paul Hardman joins as Head of Scientific Affairs. This latest appointment further bolsters the ...

FDA - Clarification on General Enforcement ...

April 30, 2021

Broughton Chief Regulatory Officer, Dr Nveed Chaudhary shares his thoughts on the latest FDA announcement, ‘Clarification on General ...

90 days and counting - PMTA Deficiency Letter

February 23, 2021

Broughton  Dr Nveed Chaudhary, Chief Regulatory Officer, discusses Deficiency Letters and data gap fulfillment and why the time to act is ...

Dr Nveed Chaudhary joins Broughton and discusses ...

February 19, 2021

Broughton Chief Regulatory Officer, Dr. Nveed Chaudhary discusses business growth and Broughton’s plans to extend its service portfolio ...

PMTA - The Final Rule

February 3, 2021

Broughton Regulatory Operations Manager, Emily Saunders, discusses FDAs announcement on the final ruling for PMTA applications.

ToxHQ System For Product Formulation

January 20, 2021

Broughton Director of Product Safety and Compliance, Yvonne Wilding, discusses a leading-edge software tool designed and in use at ...

Sensitivity of analytical methods - LOD/LOQ

December 16, 2020

Broughton Chief Scientific Officer, Chris Allen, discusses the sensitivity of analytical methods appropriate for Toxicological assessment ...

What does the new TPPI guidance mean to ENDS ...

November 6, 2020

Broughton Director of Product Safety and Compliance, Yvonne Wilding, looks at the recent Tobacco Product Perception and Intention studies ...

Post Market Requirements - A journey, not a ...

October 16, 2020

Broughton , Director of Product Safety and Compliance, Yvonne Wilding has recently published an article with leading sector publication ...

Potential delay to Revision of the Tobacco ...

October 1, 2020

Emily Saunders, Regulatory Operations Manager, takes a look at the potential delay to the Tobacco Product Directive (TPD3) and the future ...

PMTA - Where next?

September 7, 2020

As the September 9th, 2020 PMTA deadline rapidly approaches, our Chief Scientific Officer, Chris Allen, takes a look at the current US ...

Counting Down to the PMTA deadline.

September 3, 2020

Broughton, Chief Scientific Officer has recently published an article with leading sector publication Tobacco Reporter – Counting Down to ...

Measuring up

August 13, 2020

Broughton, Chief Scientific Officer has recently published an article with leading sector publication Tobacco Reporter – Measuring up

What is Toxicology for ENDS

May 19, 2020

This article provides an overview of the different types of toxicological studies typically undertaken, and how they support regulatory ...

Blog: Expansion of Toxicology team at Broughton

May 1, 2020

Broughton announce expansion of Toxicology team directed by Yvonne Wilding.

Breaking news: PMTA deadline extension agreed

April 22, 2020

Extension of the Premarket Tobacco Product Application (PMTA) deadline, requested by the US Food and Drug Administration (FDA) due to the ...

Update on Premarket Tobacco Product Application ...

April 6, 2020

A recent announcement from The Food and Drug Administration (FDA) on the Premarket Tobacco Authorization (PMTA) final ruling means that the ...

FDA requests PMTA deadline extension

March 31, 2020

The US Food and Drug Administration (FDA) has requested an extension to the Premarket Tobacco Product Application (PMTA) deadline due to ...

Broughton launches toxicology services department ...

March 4, 2020

We’re delighted to announce that Broughton has launched an in-house toxicology services division to increase our capacity and introduce ...

Safeguarding the smoking gun

February 19, 2020

Alan Hutchinson, Principal Scientist at Broughton, has recently published an article with Laboratory News; the leading magazine for UK ...

ENDS manufacturers encouraged to take the lead on ...

January 31, 2020

Are you confused by the ENDS flavor debate? Dr. Ian Fearon, Broughton subject matter expert for clinical studies, has recently published an ...

US ENDS total flavor ban? Not quite.

January 3, 2020

The US Food and Drug Administration (FDA) has published final guidance regarding Enforcement Priorities for Electronic Nicotine Delivery ...

US ENDS market at its crossroads

December 16, 2019

Turn left or turn right?

Broughton launch service to help determine impact ...

December 10, 2019

We’re delighted to announce that Broughton has recently launched an in-house service focused on enabling companies in the Electronic ...

Broughton research facility gathers pace with ...

November 19, 2019

We are delighted to announce that Broughton has made a series of major business transactions to meet the demands of our growing portfolio.

What does the Proposed Rule mean for ENDS ...

October 22, 2019

The US Food and Drug Administration (FDA) recently published a “Proposed Rule” for the Electronic Nicotine Delivery Systems (ENDS) sector. ...

FDA proposes additions to the HPHC list

August 9, 2019

 

The 10-month PMTA deadline is confirmed.

July 15, 2019

 

ENDS HPHCs - What's new and why?

July 10, 2019

As we mentioned in our previous article, Final PMTA guidance has arrived – what’s changed?, FDA has modified the list of constituents or ...

Final PMTA guidance has arrived – What’s changed?

June 21, 2019

 

Maryland ruling - will this bring the PMTA ...

June 17, 2019

Do e-cigarette flavors increase cardiovascular ...

June 13, 2019

 

Have you got your PMTA team in place?

May 24, 2019

 

What is a PMTA?

May 8, 2019

 

It's all ENDS in Miami

May 3, 2019

 

Could clarity for US ENDS companies be imminent?

April 3, 2019

The latest statement from FDA Commissioner, Scott Gottlieb, outlines the agency’s actions to ensure sound regulation of tobacco products, ...

Latest guidance issued by FDA on requirements for ...

March 27, 2019

Tobacco product manufacturers are required to comply with certain requirements under Section 904(a) of the Federal Food, Drug and Cosmetic ...

Broughton expands its nicotine services business

March 21, 2019

We are delighted to officially announce the recent launch of Broughton Limited, a spin-off from the long-established Broughton. The new ...

Is a week a long time in the US ENDS industry?

March 14, 2019

It appears so, following a series of significant recent FDA announcements regarding Harmful and Potentially Harmful Constituent (HPHC) ...

Harmful and Potentially Harmful Constituents ...

March 12, 2019

BACKGROUND

Schedule a meeting with the FDA Center for ...

February 20, 2019

FDA regulated industries, including the ENDS industry, have few opportunities to engage with the FDA and receive valuable, bespoke product ...

PMTA readiness update from the Keller and Heckman ...

February 7, 2019

Jan 2019, Miami, USA.
Contact us

From basic questions to complex compliance inquiries, we're here to help! Contact us today.